Literature DB >> 29544639

The Ovarian Hyperstimulation Syndrome.

Zeev Blumenfeld1.   

Abstract

The ovarian hyperstimulation syndrome (OHSS) is an iatrogenic syndrome, which may, infrequently, become severe and evenly fatal. Until the last decade, the worldwide popularity of assisted reproductive technology (ART) and ovulation induction/controlled ovarian hyperstimulation employed in ART for either in vivo fertilization or in vitro fertilization, in the last two decades, has been accompanied by an increase in the cases of OHSS. In the last decade, the substitution of the human chorionic gonadotropin trigger with the gonadotropin-releasing hormone agonist trigger has decreased the incidence of this syndrome but did not eliminate it completely. We summarize here the classification, pathophysiology, and treatment of the OHSS.
© 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ascites; Ovarian hyperstimulation syndrome; Ovary; Pathophysiology; Vascular permeability

Mesh:

Year:  2018        PMID: 29544639     DOI: 10.1016/bs.vh.2018.01.018

Source DB:  PubMed          Journal:  Vitam Horm        ISSN: 0083-6729            Impact factor:   3.421


  17 in total

1.  Assessing the Usefulness of Severity Markers in Women with Ovarian Hyperstimulation Syndrome.

Authors:  Aleksei Petrovich Petrenko; Camil Castelo-Branco; Dimitry Vasilevich Marshalov; Alexander Valerievich Kuligin; Efim Munevich Shifman; Elena Sergeevna Nesnova
Journal:  Reprod Sci       Date:  2020-10-15       Impact factor: 3.060

2.  Sudden death of an egg donor during oocyte retrieval due to ovarian hyperstimulation syndrome.

Authors:  Swati Tyagi; Asit Ranjan Mridha; Chittaranjan Behera
Journal:  Autops Case Rep       Date:  2022-05-27

3.  An update of polycystic ovary syndrome: causes and therapeutics options.

Authors:  Abeer M Rababa'h; Bayan R Matani; Alaa Yehya
Journal:  Heliyon       Date:  2022-10-10

4.  Are anthropometric data a tool for determining the severity of OHSS? Yes, it could be!

Authors:  Aleksei Petrovich Petrenko; Camil Castelo-Branco; Dimitry Vasilevich Marshalov; Alexander Valerievich Kuligin; Efim Munevich Shifman; Elena Sergeevna Nesnova; Batsunova Mariia Olegovna
Journal:  BMC Womens Health       Date:  2022-05-10       Impact factor: 2.742

5.  Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI.

Authors:  Bo Sun; Yujia Ma; Lu Li; Linli Hu; Fang Wang; Yile Zhang; Shanjun Dai; Yingpu Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-19       Impact factor: 5.555

6.  A Prospective Randomised Comparative Clinical Trial Study of Luteal PhaseLetrozole versus Ganirelix Acetate Administration to Prevent Severity of Early Onset OHSS in ARTs.

Authors:  Rana Afzal Choudhary; Priyanka H Vora; Kavita K Darade; Seema Pandey; Kedar N Ganla
Journal:  Int J Fertil Steril       Date:  2021-10-16

7.  Clinical Pregnancy and Incidence of Ovarian Hyperstimulation Syndrome in High Ovarian Responders Receiving Different Doses of hCG Supplementation in a GnRH-Agonist Trigger Protocol.

Authors:  Xiuzhen Shen; Qinjie Yang; Lanfang Li; Wenhao Lu
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-25       Impact factor: 2.629

8.  Tie1 contributes to the development of ovarian hyperstimulation syndrome under the regulation of EGR1 in granulosa cells.

Authors:  Lihua Sun; Hui Tian; Songguo Xue; Hongjuan Ye; Xue Xue; Rongxiang Wang; Yu Liu; Caixia Zhang; Qiuju Chen; Shaorong Gao
Journal:  Exp Mol Med       Date:  2022-01-25       Impact factor: 12.153

9.  Live-Birth Prediction of Natural-Cycle In Vitro Fertilization Using 57,558 Linked Cycle Records: A Machine Learning Perspective.

Authors:  Yanran Zhang; Lei Shen; Xinghui Yin; Wenfeng Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-22       Impact factor: 6.055

10.  The influence of frozen-thawed and fresh embryo transfer on utero-placental (vascular) development: the Rotterdam Periconception cohort.

Authors:  Linette van Duijn; Melek Rousian; Igna F Reijnders; Sten P Willemsen; Esther B Baart; Joop S E Laven; Régine P M Steegers-Theunissen
Journal:  Hum Reprod       Date:  2021-07-19       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.